These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


644 related items for PubMed ID: 27215335

  • 1. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.
    Li J, Zou M, Dou Q, Hu Y, Wang H, Yan Q, Liu WE.
    Ann Clin Microbiol Antimicrob; 2016 May 23; 15(1):35. PubMed ID: 27215335
    [Abstract] [Full Text] [Related]

  • 2. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).
    Shu JC, Chia JH, Siu LK, Kuo AJ, Huang SH, Su LH, Wu TL.
    Int J Antimicrob Agents; 2012 Mar 23; 39(3):217-22. PubMed ID: 22079532
    [Abstract] [Full Text] [Related]

  • 3. Characterization and genetic analysis of extensively drug-resistant hospital acquired Pseudomonas aeruginosa isolates.
    Abdelaziz MA, El-Aziz AMA, El-Sokkary MMA, Barwa R.
    BMC Microbiol; 2024 Jun 26; 24(1):225. PubMed ID: 38926687
    [Abstract] [Full Text] [Related]

  • 4. Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital.
    Kiddee A, Henghiranyawong K, Yimsabai J, Tiloklurs M, Niumsup PR.
    Int J Antimicrob Agents; 2013 Oct 26; 42(4):301-6. PubMed ID: 23845503
    [Abstract] [Full Text] [Related]

  • 5. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa.
    De Rosa A, Mutters NT, Mastroianni CM, Kaiser SJ, Günther F.
    Eur J Clin Microbiol Infect Dis; 2019 Aug 26; 38(8):1547-1552. PubMed ID: 31152264
    [Abstract] [Full Text] [Related]

  • 6. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R, Mulet X, Ivanov I, Zamorano L, Dobreva E, Velinov T, Kantardjiev T, Oliver A.
    Microb Drug Resist; 2013 Oct 26; 19(5):355-61. PubMed ID: 23600605
    [Abstract] [Full Text] [Related]

  • 7. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR, Rajabpour M, Yousefi Mashouf R, Alikhani MY, Mousavi SM.
    Arch Iran Med; 2015 Feb 26; 18(2):102-8. PubMed ID: 25644798
    [Abstract] [Full Text] [Related]

  • 8. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B, Estepa V, Cebollada R, de Toro M, Somalo S, Seral C, Castillo FJ, Torres C, Sáenz Y.
    Int J Med Microbiol; 2014 May 26; 304(3-4):405-14. PubMed ID: 24594145
    [Abstract] [Full Text] [Related]

  • 9. [The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa].
    Yi MY, Wang PY, Huang HJ, Liu YC.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 21; 86(7):457-62. PubMed ID: 16677571
    [Abstract] [Full Text] [Related]

  • 10. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
    Maniati M, Ikonomidis A, Mantzana P, Daponte A, Maniatis AN, Pournaras S.
    J Antimicrob Chemother; 2007 Jul 21; 60(1):132-5. PubMed ID: 17483142
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic and genotypic detection of antibiotic resistance of Pseudomonas aeruginosa isolated from urinary tract infections.
    Abbas HA, El-Ganiny AM, Kamel HA.
    Afr Health Sci; 2018 Mar 21; 18(1):11-21. PubMed ID: 29977252
    [Abstract] [Full Text] [Related]

  • 12. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G, Pollini S, Docquier JD, Almuzara M, Gutkind G, Rossolini GM, Radice M.
    Rev Panam Salud Publica; 2011 Dec 21; 30(6):545-8. PubMed ID: 22358400
    [Abstract] [Full Text] [Related]

  • 13. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons.
    Yan JJ, Hsueh PR, Lu JJ, Chang FY, Ko WC, Wu JJ.
    J Antimicrob Chemother; 2006 Sep 21; 58(3):530-6. PubMed ID: 16816399
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of the integrons of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan.
    Mano Y, Saga T, Ishii Y, Yoshizumi A, Bonomo RA, Yamaguchi K, Tateda K.
    BMC Microbiol; 2015 Feb 21; 15():41. PubMed ID: 25881168
    [Abstract] [Full Text] [Related]

  • 15. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
    Martins WMBS, Narciso AC, Cayô R, Santos SV, Fehlberg LCC, Ramos PL, da Cruz JB, Gales AC.
    Diagn Microbiol Infect Dis; 2018 Mar 21; 90(3):221-227. PubMed ID: 29224710
    [Abstract] [Full Text] [Related]

  • 16. Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital.
    Liu Y, Li XY, Wan LG, Jiang WY, Li FQ, Yang JH.
    Microb Drug Resist; 2013 Dec 21; 19(6):463-8. PubMed ID: 23865862
    [Abstract] [Full Text] [Related]

  • 17. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY, Ko KS.
    Int J Antimicrob Agents; 2012 Aug 21; 40(2):168-72. PubMed ID: 22633564
    [Abstract] [Full Text] [Related]

  • 18. Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.
    Ozgumus OB, Caylan R, Tosun I, Sandalli C, Aydin K, Koksal I.
    Microb Drug Resist; 2007 Aug 21; 13(3):191-8. PubMed ID: 17949306
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
    Bubonja-Sonje M, Matovina M, Skrobonja I, Bedenic B, Abram M.
    Microb Drug Resist; 2015 Jun 21; 21(3):261-9. PubMed ID: 25565041
    [Abstract] [Full Text] [Related]

  • 20. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, Li LJ.
    Int J Antimicrob Agents; 2010 May 21; 35(5):486-91. PubMed ID: 20185276
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.